StreetAlpha.app
Home › Stocks › KVUE

Kenvue Inc. (KVUE)

Consumer Defensive
$19.29
▼ −1.38%
LAST CLOSE · OCT 30

Kenvue sells consumer health products, including pain relievers, skin care, oral care and baby care items sold worldwide. It last closed at $19.29 on Oct 30, down 1.38% on the day. KVUE last reported earnings on Fri, Oct 30, 2026. In the past 30 days there were 1 dark pool print totaling $593K, the largest $593K.

AI Auto Pilots
Is KVUE in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$15.5B
+3.5% vs a year ago
Net income
$1.7B
+17.9% vs a year ago
EPS (diluted)
$0.88
+17.3% vs a year ago
Free cash flow
$2.3B
15.1% margin
Valuation
Market cap
$37.1B
1.92B shares
P/E
21.9
Price over 12 month EPS
Price to sales
2.4
Market cap over revenue
Dividend yield
5.39%
$1.04 a share over 12 months
Balance sheet
Cash & equivalents
$1.0B
At Sep 27
Shareholder equity
$10.2B
Shares outstanding
1.92B
At Oct 26
Fiscal year endsJanuary
ExchangeNYSE
Financials history
FY2022: $15.1B$15.1BFY2022FY2023: $14.9B$14.9BFY2023FY2023: $15.4B$15.4BFY2023FY2024: $15.5B$15.5BFY2024FY2025: $15.1B$15.1BFY2025

From KVUE's SEC filings, latest 10-Q for the period ending Sep 27, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Last report
Oct 30
2026 · Before the open (BMO)
Reported EPS
$0.29
vs $0.28 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±2.1%
Priced in before that report
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated KVUE in the past 90 days.
Average 12-month target
No price targets on KVUE in the past 90 days.
Latest rating changes
UBSMaintained
Jul 16Hold$20
DateFirmActionRatingPrice target
Jul 16UBSMaintainedHold$20
Loading…

Technical Analysis

KVUE · as of the Oct 30 close · updated after every close
Uptrend

The stock is 3% above its 20 day and 5% above its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 60). The nearest support is the Pivot S1 at $19.01, and the nearest resistance the swing high (Jul 17) at $19.36.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 2.0%/day
Key levels
$20.1352 week high+4.2%
$19.81Pivot R1+2.6%
$19.50Pivot+1.0%
$19.36Swing high (Jul 17)+0.3%
$19.31Last close
$19.01Pivot S1−1.6%
$18.77Swing low (Jul 23)−2.8%
$18.70100 day average−3.2%
$18.6420 day average−3.5%
$18.4150 day average−4.7%
$18.19200 day average−5.8%
$14.0252 week low−27.4%
Indicators
RSI (14)59.98Middle of its rangeNeutral
MACD0.40Above its signal lineBullish
Stochastic78.3Middle of its rangeNeutral
ADX (14)34.5Trending up
Williams %R-28.1Oversold below −80, overbought above −20Neutral
CCI (20)76.6Oversold below −100, overbought above 100Neutral
Rate of change+2.1%Change over 10 sessionsBullish
ATR (14)$0.38Typical daily range, 2.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for KVUE

What happened before

See how KVUE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow KVUE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How KVUE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in KVUE in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$593K
Largest print
$593K
Loading…

KVUE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●468 buying vs 482 selling
  • ▼Shares held by funds -4.0%
  • ▼Funds holding -15
  • ▲Superinvestors: 4 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1,0021,017−1.5%
In funds' top 102426−7.7%
Held by funds–––
New / increased87 / 38199 / 411−8.2%
Reduced / sold out391 / 91365 / 103+3.0%
Put/call ratio0.750.29+161.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KVUE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

KVUE Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$0
0.0% yield
Left in program
6.6M sh
0.3% of shares
Shares outstanding, 12 months
+0.3%
More shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $120.2M
Dec 2023: $7.2M, average price $20.47Mar 2024: $91.0M, average price $19.79Jun 2024: $0Sep 2024: $23.4M, average price $21.30Dec 2024: $120.2M, average price $23.31Mar 2025: $62.8M, average price $20.94Jun 2025: $63.7M, average price $23.88Sep 2025: $70.8M, average price $20.16Dec 2025: $0Mar 2026: $0Jun 2026: $0Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KVUE is in one of them and how their past KVUE trades turned out.

KVUE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KVUE in an article yet. Here's the latest on the wider market.

KVUE Congress Trades

All congress trades →
Trades, 12 months
26
Buys
15
58%
Sells
11
42%
People
7
Last filed Sep 4
Who traded KVUE · since 2023
Latest 5 filings of 55
Gilbert CisnerosSell (partial)
$1K – $15KTraded Jul 17, 2026Filed Sep 4, 2026
$1K – $15KTraded Aug 5, 2026Filed Aug 10, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jun 2, 2026Filed Jul 6, 2026
$1K – $15KTraded Jun 16, 2026Filed Jul 2, 2026
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CASell (partial)$1K – $15KJul 17, 2026Sep 4, 202649 d
Kevin HernR · OKSell$1K – $15KAug 5, 2026Aug 10, 20265 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CABuy$1K – $15KJun 2, 2026Jul 6, 202634 d
Gilbert CisnerosD · CABuy$1K – $15KJun 16, 2026Jul 2, 202616 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Kenvue

Kenvue is a consumer health company based in Summit, New Jersey. It makes over the counter medicines such as pain relievers and allergy treatments, along with skin and hair care, oral care, baby care, wound care and menstrual products. Well known brands include Tylenol, Listerine, Neutrogena and Johnson's. Its products are sold to consumers in many countries, and healthcare professionals help shape product development.

Headquarters
Summit, NJ